MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma von Hegi, Monika E, Diserens, Annie-Claire, Gorlia, Thierry, Hamou, Marie-France, de Tribolet, Nicolas, Weller, Michael, Kros, Johan M, Hainfellner, Johannes A, Mason, Warren, Mariani, Luigi, Bromberg, Jacoline E.C, Hau, Peter, Mirimanoff, René O, Cairncross, J. Gregory, Janzer, Robert C, Stupp, Roger

Volltext

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial von Gao, Y., Weenink, B., van den Bent, M.J., Erdem-Eraslan, L., Kros, J.M., Sillevis Smitt, PAE, Hoang-Xuan, K., Brandes, A.A., Vos, M., Dhermain, F., Enting, R., Ryan, G.F., Chinot, O., Ben Hassel, M., van Linde, M.E., Mason, W.P., Gijtenbeek, J.M.M., Balana, C., von Deimling, A., Gorlia, Th, Stupp, R., Hegi, M.E., Baumert, B.G., French, P.J.

Volltext

Detection of Meningioma in Dura Mater by Raman Spectroscopy von Koljenović, Senada, Schut, Tom Bakker, Vincent, Arnaud, Kros, Johan M, Puppels, Gerwin J

Volltext

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group S... von VAN DEN BENT, M. J, TAPHOORN, M. J. B, ALLGEIER, A, GORLIA, T, BRANDES, A. A, MENTEN, J, STUPP, R, FRENAY, M, CHINOT, O, KROS, J. M, VAN DER RIJT, C. C. D, VECHT, Ch. J

Volltext

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors von Pivonello, Rosario, Ferone, Diego, de Herder, Wouter W., Kros, Johan M., Del Basso De Caro, Maria Laura, Arvigo, Marica, Annunziato, Lucio, Lombardi, Gaetano, Colao, Annamaria, Hofland, Leo J., Lamberts, Steven W. J.

Volltext

Tissue characterization using high wave number Raman spectroscopy von Koljenovic´, S, Bakker Schut, T. C, Wolthuis, R, de Jong, B, Santos, L, Caspers, P. J, Kros, J. M, Puppels, G. J

Volltext

Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours von de Jong, Jeroen, Stoop, Hans, Dohle, Gert R, Bangma, Chris H, Kliffen, Mike, van Esser, Joost WJ, van den Bent, Martin, Kros, Johan M, Oosterhuis, JW, Looijenga, Leendert HJ

Volltext

Oligodendrogliomas with Neurocytic Differentiation. A Report of 4 Cases with Diagnostic and Histogenetic Implications von PERRY, ARIE, SCHEITHAUER, BERND W, MACAULAY, ROBERT J. B, RAFFEL, COREY, ROTH, KEVIN A, KROS, JOHAN M

Volltext

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features von van den Bent, Martin J., Looijenga, Leendert H. J., Langenberg, K., Dinjens, Winand, Graveland, Wilfried, Uytdewilligen, Ludo, Sillevis Smitt, Peter A., Jenkins, Robert B., Kros, Johan M.

Volltext

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 2... von van den Bent, M. J., Chinot, O., Boogerd, W., Bravo Marques, J., Taphoorn, M. J. B., Kros, J. M., van der Rijt, C. C. D., Vecht, C. J., De Beule, N., Baron, B.

Volltext

Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies von Coesmans, Michiel, Sillevis Smitt, Peter A., Linden, David J., Shigemoto, Ryuichi, Hirano, Tomoo, Yamakawa, Yoshinori, Van Alphen, Adriaan M., Luo, Chongde, Van Der Geest, Josef N., Kros, Johan M., Gaillard, Carlo A., Frens, Maarten A., De Zeeuw, Chris I.

Volltext

Discriminating Vital Tumor from Necrotic Tissue in Human Glioblastoma Tissue Samples by Raman Spectroscopy von Koljenović, Senada, Choo-Smith, Lin-P'ing, Bakker Schut, Tom C, Kros, Johan M, van den Berge, Herbert J, Puppels, Gerwin J

Volltext

Medical applications of Raman spectroscopy: From proof of principle to clinical implementation von Choo-Smith, L.-P., Edwards, H. G. M., Endtz, H. P., Kros, J. M., Heule, F., Barr, H., Robinson Jr, J. S., Bruining, H. A., Puppels, G. J.

Volltext

Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas von Kurt, Erkan, Zheng, Ping‐Pin, Hop, Wim C. J., van der Weiden, Marcel, Bol, Meike, van den Bent, Martin J., Avezaat, Cees J. J., Kros, Johan M.

Volltext

Gene expression profiles associated with treatment response in oligodendrogliomas von FRENCH, Pim J, SWAGEMAKERS, Sigrid M. A, NAGEL, Jord H. A, KOUWENHOVEN, Mathilde C. M, BROUWER, Eric, VAN DER SPEK, Peter, LUIDER, Theo M, KROS, Johan M, VAN DEN BENT, Martin J, SILLEVIS SMITT, Peter A

Volltext

Successful treatment of low‐grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine von Stege, Elize M. Biemond‐ter, Kros, Johan M., de Bruin, Hein G., Enting, R. H., van Heuvel, Irene, Looijenga, Leendert H. J., van der Rijt, Carin D. D., Smitt, Peter A. E. Sillevis, van den Bent, Martin J.

Volltext

Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas von WATANABE, Takao, NAKAMURA, Mitsutoshi, KROS, Johan M, BURKHARD, Christoph, YONEKAWA, Yasuhiro, KLEIHUES, Paul, OHGAKI, Hiroko

Volltext

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas von TRIEBELS, V. H. J. M, TAPHOORN, M. J. B, VAN HEUVEL, I, VAN DEN BENT, M. J, BRANDES, A. A, MENTEN, J, FRENAY, M, TOSONI, A, KROS, J. M, BIEMOND-TER STEGE, E, ENTING, R. H, ALLGEIER, A

Volltext

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery von van Veelen, M L C, Avezaat, C J J, Kros, J M, van Putten, W, Vecht, Ch

Volltext

From expert opinion to evidence-based: changes in the gold standard of primary brain tumour diagnosis von Kros, JM

Volltext